Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
6
×
biotech
boston top stories
national top stories
new york blog main
san francisco blog main
boston
clinical trials
new york top stories
san diego blog main
san francisco top stories
detroit blog main
detroit top stories
fda
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
drugs
financing
funding
indiana blog main
indiana top stories
ipo
major depressive disorder
medical devices
national
san francisco
startups
accelerator
What
biotechs
6
×
ipo
ipos
life
ago
companies
firms
medicines
new
science
sciences
therapeutics
way
week
admits
approach
bags
big
capital
central
chose
classes
close
club
cns
combinator
company
considering
continued
crop
data
device
diseases
disorder
drug
drugs
dug
dyne
early
emerged
Language
unset
Current search:
biotechs
×
" national blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M